165 related articles for article (PubMed ID: 1868308)
1. Possible significance of familial aggregations of multiple sclerosis.
Mumford C
Br J Hosp Med; 1991 Jul; 46(1):55-7. PubMed ID: 1868308
[TBL] [Abstract][Full Text] [Related]
2. The increased susceptibility of women to multiple sclerosis.
Duquette P; Pleines J; Girard M; Charest L; Senecal-Quevillon M; Masse C
Can J Neurol Sci; 1992 Nov; 19(4):466-71. PubMed ID: 1423044
[TBL] [Abstract][Full Text] [Related]
3. Association and linkage of juvenile MS with HLA-DR2(15) in Russians.
Boiko AN; Gusev EI; Sudomoina MA; Alekseenkov AD; Kulakova OG; Bikova OV; Maslova OI; Guseva MR; Boiko SY; Guseva ME; Favorova OO
Neurology; 2002 Feb; 58(4):658-60. PubMed ID: 11865153
[TBL] [Abstract][Full Text] [Related]
4. A humanized model for multiple sclerosis using HLA-DR2 and a human T-cell receptor.
Madsen LS; Andersson EC; Jansson L; krogsgaard M; Andersen CB; Engberg J; Strominger JL; Svejgaard A; Hjorth JP; Holmdahl R; Wucherpfennig KW; Fugger L
Nat Genet; 1999 Nov; 23(3):343-7. PubMed ID: 10610182
[TBL] [Abstract][Full Text] [Related]
5. Multiple sclerosis in Australia and New Zealand: are the determinants genetic or environmental?
Miller DH; Hammond SR; McLeod JG; Purdie G; Skegg DC
J Neurol Neurosurg Psychiatry; 1990 Oct; 53(10):903-5. PubMed ID: 2266373
[TBL] [Abstract][Full Text] [Related]
6. Twin studies in multiple sclerosis.
Heltberg A
Ital J Neurol Sci; 1987 Jun; Suppl 6():35-9. PubMed ID: 3498704
[TBL] [Abstract][Full Text] [Related]
7. HLA-DR2 and white matter lesion distribution in MS.
Sepulcre J; Masdeu JC; Palacios R; Goñi J; Moreno B; Tainta M; Bejarano B; Villoslada P
J Neuroimaging; 2008 Jul; 18(3):328-31. PubMed ID: 18482373
[TBL] [Abstract][Full Text] [Related]
8. [HLA and familial multiple sclerosis].
Barroche G; Perrier P; Raffoux C; Gehin P; Streiff F; Weber M
Rev Neurol (Paris); 1986; 142(10):738-45. PubMed ID: 3823705
[TBL] [Abstract][Full Text] [Related]
9. Genetic control of multiple sclerosis: increased production of lymphotoxin and tumor necrosis factor-alpha by HLA-DR2+ T cells.
Zipp F; Weber F; Huber S; Sotgiu S; Czlonkowska A; Holler E; Albert E; Weiss EH; Wekerle H; Hohlfeld R
Ann Neurol; 1995 Nov; 38(5):723-30. PubMed ID: 7486863
[TBL] [Abstract][Full Text] [Related]
10. Concordance for disease course and age of onset in Scandinavian multiple sclerosis coaffected sib pairs.
Oturai AB; Ryder LP; Fredrikson S; Myhr KM; Celius EG; Harbo HF; Andersen O; Akesson E; Hillert J; Madsen HO; Nyland H; Spurkland A; Datta P; Svejgaard A; Sorensen PS
Mult Scler; 2004 Feb; 10(1):5-8. PubMed ID: 14760946
[TBL] [Abstract][Full Text] [Related]
11. Multiple sclerosis immunopathic trait and HLA-DR(2)15 as independent risk factors in multiple sclerosis.
Callander M; Haghighi S; Landtblom AM; Ahlgren CE; Nilsson SI; Rydberg L; Al Khoury H; Rosegren L; Andersen O
Mult Scler; 2007 May; 13(4):441-5. PubMed ID: 17463066
[TBL] [Abstract][Full Text] [Related]
12. HLA antigens and multiple sclerosis in Northern Ireland.
Hawkins SA; Cullen C; Middleton D; Morrow JI
Ir J Med Sci; 1990 Mar; 159(3):68-70. PubMed ID: 2361821
[TBL] [Abstract][Full Text] [Related]
13. [Immunogenetics of multiple sclerosis].
Clanet M; Cambon-Thomsen A; Rascol A
Pathol Biol (Paris); 1987 Mar; 35(3):299-302. PubMed ID: 3295695
[TBL] [Abstract][Full Text] [Related]
14. C4AQ0 and HLA-DR2, risk factors in multiple sclerosis.
Marcelli-Barge A; Poirier JC; Chantome R; Lepage V; Khalil I; Colombani J
Res Immunol; 1990 Oct; 141(8):739-41. PubMed ID: 2089531
[No Abstract] [Full Text] [Related]
15. Modelling genetic susceptibility to multiple sclerosis with family data.
O'Gorman C; Lin R; Stankovich J; Broadley SA
Neuroepidemiology; 2013; 40(1):1-12. PubMed ID: 23075677
[TBL] [Abstract][Full Text] [Related]
16. [Multiple sclerosis viewed from the point of HTLV-I associated myelopathy].
Osame M; Arimura K; Nakagawa M
Rinsho Shinkeigaku; 1995 Dec; 35(12):1498-500. PubMed ID: 8752443
[TBL] [Abstract][Full Text] [Related]
17. Familial recurrence risks and inheritance of multiple sclerosis.
Sadovnick AD
Curr Opin Neurol Neurosurg; 1993 Apr; 6(2):189-94. PubMed ID: 8481562
[TBL] [Abstract][Full Text] [Related]
18. Interaction between ESR1 and HLA-DR2 may contribute to the development of MS in women.
Mattila KM; Luomala M; Lehtimäki T; Laippala P; Koivula T; Elovaara I
Neurology; 2001 May; 56(9):1246-7. PubMed ID: 11342704
[No Abstract] [Full Text] [Related]
19. Epidemiology of multiple sclerosis in Australia. With NSW and SA survey results.
McLeod JG; Hammond SR; Hallpike JF
Med J Aust; 1994 Feb; 160(3):117-22. PubMed ID: 8295576
[TBL] [Abstract][Full Text] [Related]
20. [Multiple sclerosis--a disease with complex genetics].
Myhr KM; Harbo HF
Tidsskr Nor Laegeforen; 2003 Oct; 123(19):2723-6. PubMed ID: 14600746
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
